Selah Genomics' Management Buyout - II Round

Selah Genomics raised a round of funding on December 24, 2015. Investors include Management Buyout (MBO).

Selah Genomics is a clinical diagnostic specialist supporting healthcare providers and the pharmaceutical industry with advanced molecular and genomic diagnostic services. Selah's services add value t…

Articles about Selah Genomics' Management Buyout - II Round: